DADilek Arpaci

Dilek Arpaci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dilek Arpaci has a total of 101 co-authors. Here are the top co-authors by number of shared publications:

  • Bekir Cakir

    Department of Endocrinology and Metabolism, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara 06010, Türkiye

    6 shared publications
  • Reyhan Ersoy

    Ankara Ataturk Education and Research Hospital

    6 shared publications
  • Taner Bayraktaroglu

    Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey

    6 shared publications
  • Fatih Kuzu

    A Bulent Ecevit University , Faculty of Medicine, Department of Endocrinology and Metabolism , Zonguldak , Turkey

    5 shared publications
  • Fatma Saglam

    Yildirim Beyazit University, Turkey

    5 shared publications
  • Ali Tamer

    Department of Internal Medicine, Faculty of Medicine, Sakarya University, Sakarya, Turkey

    3 shared publications

Latest Publications

  • Open Access

    The Clinical Values of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Blood and Thyroid Nodules

    by Ayfer Altas, Fatih Kuzu, Dilek Arpaci, Mustafa Unal, Murat Can, Figen Barut, Furuzan Kokturk, Sevil Uygun Ilikhan, Taner Bayraktaroglu

    Aim.Insulin-like growth factor-1 (IGF-1) is a potent mitogen for many cells. IGF-1 plays a role in the pathogenesis of various tumors with its mutagenic and antiapoptotic properties. The aim of this study was to determine both the serum and intranodular levels of IGF-1 and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with nodular thyroid diseases.Materials and Methods.In this study, 80 subjects who performed fine-needle aspiration biopsy (FNAB) were required in order to investigate the effects of serum and intranodular IGF-1 and IGFBP-3 in the pathogenesis of nodules. After performing FNAB, IGF-1 and IGFBP-3 levels were determined in blood and aspiration samples.Results.The serum levels of IGF-1 (232.8 ± 12.9 ng/ml) and IGFBP-3 (4.8 μg/ml) were found significantly higher than that of the intranodular IGF-1 (39.1 ng/ml) and intranodular IGFBP-3 levels (0.173 μg/ml) (p<0.01). Intranodular levels of IGF-1 and IGFBP-3 were higher in subjects with multinodular thyroid gland than those of subjects with solitary nodules (p=0.043). A positive correlation between the nodule size and the serum IGFBP-3 levels was detected (p=0.042,r=0.23).Conclusion.This study demonstrated the possible role of both IGF-1 and IGFBP-3 in the growth and the formation of multinodularity of thyroid nodules.


  • Clinical presentations of four patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumor syndrome

    by Taner Bayraktaroglu, Utku Sentosun, Dilek Karakaya Arpaci, Ali Ugur Emre, Mertol Gokce, Serkan Uysal, Rabiye Uslu Erdemir, Burak Bahadir, Guldeniz Karadeniz Cakmak

    Introduction: Primary hyperparathyroidism is commonly treated with targeted parathyroidectomy guided by preoperative imaging and intraoperative parathormone monitoring. Despite advanced imaging techniques, failure of parathyroid localization still occurs. Hyperparathyroidism-jaw tumor syndrome and familial isolated hyperparathyroidism are a rare autosomal dominant tumor syndrome characterized by hyperparathyroidism. In this report, we present four patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumor syndrome, below. Case 1: A 26-year-old man with left maxillary tumoral lesion is referred. He had the elevated serum calcium and parathormon levels, osteoporosis, rena anomalia, nephrolitiasis, Acording to the diagnosis of hyperparathyroidism jaw-tumor syndrome, imaging modalities included neck sonography, scintigraphy, computerized tomography indicaed that a ectopic parathyroidal adenoma, then it was removed by videoscopic assisted medastinoscopy with temporarily hypoparathyroidism. Case 2: A 43-year-old-man who is a relative of Case 1 is presented with persistent myalgia-arthralgia and nausea due to hypercalcemia caused by increased parathormon levels. Sonographic and scintigraphical evaluations of the neck showed that multiple irregular nodules of thyroid and suspected parathyroid adenomas. Fine neddle aspiration cytology of the nodules and pathological lymphadenopathy revealed a suspect of the low differentiated thyroidal carcinoma with lymphatic invasion. In wash-out sampling from suspected parathyroid adenoma, parathormon levels were increased. Total thyroidectomy with central and lateral neck dissection in addition adenomectomy with hungry bone syndrome. Case 3: A 600-year-old-man who is in relations with Case 1 and Case 2 is complained with nausea-vomiting and lower back pain with osteoporotic fractures of left femur and left humerus. His serum levels of calcium and parathormon are highly increased. Imaging modalities showed a suspected lesion in the inferior region of the left thyroidal localization. After minimal invasive intervention and selective parathyroid sampling, the second operation included exploration and thyroidectomy with 3.5 paratyhroidectomy and implantation to sternocleidomastoid muscles were performed. Postoperatively, he had hypothyroidism with elevated serum calcium and parathormon levels. Thereafter hybrid nuclear modalities showed a suspected paratrakeal lesion, the case referred to reoperation with radioguided parathyroid surgery. Case 4: The patient was a 51-year-old man (who is a brother of Case 3) presenting without any symptoms. He had hypercalcemia (12.2 mg/dl) and hyperparathyroidism (247 pg/ml). Parathyroid lesion detected with sonography and scintigraphical evaluations, and it is referred to minimal invasive parathyroid adenomectomy. Conclusion: Primary hyperparathyroidism is a common clinical problem for which the only definitive management is surgery. Diagnosis of the familial primary hyperparathyroidism caused by CDC73 (formerly known as HRPT2) is based on the biochemical findings of primary hyperparathyroidism, identification of ossifying fibroma(s) of the maxilla and/or mandible on imaging studies, family history, and detection of a heterozygous germline CDC73pathogenic variant on molecular genetic testing. The spectrum of CDC73-related disorders includes hyperparathyroidism-jaw tumor syndrome, familial isolated hyperparathyroidism and parathyroid carcinoma, In familial primary hyperparathyroidism, reoperative parathyroidectomy are challenging entities that require special consideration and expertise.

  • Akromegalide Oral ve İntravenöz Glukoz Tolerans Testine Büyüme Hormonu Yanıtı

    by Güray Ceylan, Muammer Bi̇li̇ci̇, Sevil Uygun İli̇khan, Dilek Karakaya Arpaci, Taner Bayraktaroğlu, Füruzan Köktürk, Yücel Üstündağ, Murat Can

    • 1 December 2016
      • Vol. 46  (6) , 601-607

    Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.

    by Dilek Arpaci, Engin Karakece, Aysel Gurkan Tocoglu, Hasan Ergenc, Gonul Gurol, Ihsan Hakki Ciftci, Ali Tamer

    Although the relationship between atherosclerosis and overt hypothyroidism has been confirmed, it remains controversial in cases of subclinical hypothyroidism. Higher TSH and similar T4 suggest differences in set-points or differences due to diagnostic limitations regarding subclinical hypothyroidism. Endothelial dysfunction (ED) is a marker rather than a precursor of cardiovascular disease. Asymmetric dimethylarginine (ADMA) and endocan are known as novel markers of ED in various diseases. Transforming growth factor-beta (TGF-β) has a protective role against autoimmune diseases such as thyroiditis. This study aimed to determine the relationships between serum ADMA, endocan, TGF-β, and the high-sensitivity C-reactive protein (hs-CRP) levels, a proven indicator of ED, in patients with SH. Thirty-five patients with SH and 21 age- and sex-matched euthyroid subjects were included in the study. The levels of TSH, FT4, lipid parameters, endocan, ADMA, TGF-β, and hs-CRP were measured. No significant differences in age or sex were found between the patient and control groups (p=0.294 and 0.881, respectively). Mean TSH level was higher in the patient group (p=0.005), whereas mean fT4 level was similar in two groups (p=0.455). The average hs-CRP, endocan, TGF-β l level in the patient group was higher than control group (p=0.001; P=0.012; P=0.025; P<0.01 respectively). A positive correlation was found between the endocan and ADMA levels (r=0.760, p=0.000). ADMA levels also were positively correlated with hs-CRP. Both the TSH and low-density lipoprotein cholesterol (LDL-C) levels were positively correlated with the hs-CRP level. Subclinical hypothyroidism is associated with increased levels of serum endocan, ADMA, and TGF-β, which are new markers for ED. In particular, ADMA was correlated with both endocan and hs-CRP levels. These findings are suggestive for increased risk of ED and subsequent development of atherosclerosis in patients with SH.


  • Increased Serum Levels of IL-28 and IL-29 and the Protective Effect ofIL28Brs8099917 Polymorphism in Patients with Hashimoto’s Thyroiditis

    by Dilek Arpaci, Sevim Karakas Celik, Murat Can, Gunes Cakmak Genc, Fatih Kuzu, Mustafa Unal, Taner Bayraktaroglu

    Hashimoto’s thyroiditis (HT) is thought to result from decreased T helper type 2 (Th2) responses, leading to the progressive destruction of thyrocytes. IFN-λ1, -λ2, and -λ3 (also known as IL-29, IL-28A, and IL-28B, respectively) are recently described members of the IFN-λ family and have been shown to decrease the production of Th2 cytokines in vitro. However, the role and mechanism of IFN-λ1 in HT remain unknown. The purpose of this study was to examine whether IL29 and IL28B gene polymorphisms are susceptibility genes for the development of HT. Also, we investigated the effects of IL-29 and IL-28 serum levels in the pathogenesis of HT. Using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method, single-nucleotide polymorphisms (SNPs) of IL28B rs8099917 (IL28 G/T) and IL29 rs30461 (IL29 T/C) were studied in 99 patients with HT and 100 healthy controls. Considering the allelic distribution of the IL28 G/T polymorphism, a higher frequency of the G allele was observed in the control group versus the HT group. Thus, it was suggested that the G allele may be protective against HT pathogenesis (OR = 0.388, 95% CI = 0.217–0.693; p = 0.001). Our findings also demonstrated that there was a statistically significant difference in serum IL-28 and IL-29 levels between case and control groups (p < 0.001). Increased serum levels of IL-28 and IL-29 were found in patients with HT. However, we did not find a relationship between the IL29 gene polymorphism and HT. In conclusion, the IL28B gene polymorphism and serum IL-28 and IL-29 levels seem to play a role in the pathogenesis of HT.


  • A pilot study to detect oxidative stress in type 2 diabetic patients

    by Ayse C. Hamamcioglu, Zehra Safi-Oz, Yasin Hazer, Dilek Arpaci, Furuzan Kokturk


  • An acute gout attack following parathyroidectomy

    by Mustafa Unal, Dilek Arpaci, Basak Erol, Taner Bayraktaroglu

    Gout is an arthritis characterized by the deposition of monosodium urate cyristales in the joints because of chronic hyperuricemia. Infections, intravenous contrast materials, acidosis, trauma, surgical interventions can be counted as common causes of acute gout attack. The aim of this study was to present postoperative gout attack at a patient with parathyroidectomy. Case: Sixty five year old man presented with back pain and fatique was admitted to our endocrinology clinic with hypercalcemia (12.4 mg/dl) for further investigation. He had a previous history of gout disease 5 years before admission but he said never treated for gout. In the laboratory examination, her urine was 136, creatinin was 3.5, albumine was 4.1, calcium was 12.4 mg/dl, fosfor was 3 mg/dl, parathormone was 1386 ng/ml. In 24-hour-urine, calcium was measured as 365 mg/day. In his neck ultrasound, it was determined a 12×16×14 mm hypoechoic lesion consistent with a parathyroid adenoma on right inferior posterior at the inferior of gland. In urinary ultrasound, there was multiple stones. Patient transferred to generel surgery department for parathyroidectomy operation. After right inferior parathyroidectomy operation,in the second postoperative day, patient had high fever raised to 39°C, pain, swelling, limitation in movements and redness in metatarsopharyngeal joint at right foot. Other physical examinations were normal. The uric acid level was studied and measured as 11.5 mg/dl. In the diagnosis, a gout attack was thought and colchium 0.5 mg 3×1 was began for treatment. The response to that therapy was fast. About in 24 h fever was lower, pain was decreased and the general situation of patient gone well Discussion: The likely reasons for postoperative flares include fluid shifts that alter the serum urate level and may favor new medications that may elicit increases or decreases in serum urate. Gantes et al. From Spain presented two cases with pseudo-gout cases after parathyroidectomy. In their cases, gout symptoms began at second post-operative day (like our cases) and they reported that acute attack symptoms regressed with calcium replacement, using nsaid and 1 mg/day colchium. In peri-operative term, the gout attack can begin with many factors. Catobolic process in operative term, starvation or dehydration can induce the hyperuricemia and gout. Postoperative gout appears in generally 8 day after surgery. The affected joint part is same with the affected joint before surgery. If patients have previous gout history prepare for a surgery, examination of uric acid levels should be done and prophylactic colcium treatment should be given if needed.

  • Safely operated two patients in pregnancy with primary hyperparathyroidism

    by Neslihan Cuhaci, Sevgul Faki, Dilek Arpaci, Nazmiye Dincer, Gurkan Dumlu, Reyhan Ersoy, Bekir Cakir

    Introduction: Primary hyperparathyroidism (pHPT) during pregnancy is rare and associated with increased morbidity for both mother and fetus. Maternal complications of pHPT include nepfhrolithiasis, pancreatitis, cardiac arrhytmias, hypertension, nausea and vomiting. pHPT is caused by a solitary adenoma in 85–90% of patients, and the curative treatment is parathyroidectomy. Here, we presented two women who have diagnosed pHPT and operated without complications in pregnancy. Case 1: She was 20 years old and presented with abdominal pain at 8th weeks gestation. Her laboratory tests were revealed 12.2 mg/dl Ca levels, 2 mg/dl Phosphorous (P) levels and 136 pg/ml parathyroid hormone (PTH) levels and her urine Ca level was 810 mg/24 h. Her neck ultrasonography (US) revealed a hypoechoic lesion with 6.3×6.3×14.5 mm size consistent with parathyroid adenoma in the left superior of the thyroid gland. No thyroid nodule was detected. Nepfhrolithiasis was not determined. The left superior parathyroid gland was excised with minimal invasive surgery in the 9th weeks of gestation and parathyroid adenoma was excised. Case 2: Thirty-eight years old woman who was 9th weeks gestation was referred to our clinic for the high serum Ca levels. Her Ca level was 11.5 mg/dl, P level was 1.4 mg/dl, PTH level was 344 pg/ml. Her neck US revealed parathyroid adenoma in the right inferior part of the thyroid gland 2×1×1 cm with size. Also she had a nodule in the right thyroid gland. She had underwent right hemithyroidectomy and parathyroidectomy in the second trimester and parathyroid adenoma was excised. Conclusion: Since the symptoms are often non-specific in the PHPT, it can be easily misdiagnosed during pregnancy. Early recognition of pHPT, followed by appropriate management and treatment may reduce the maternal and fetal complications. Therefore pregnant women with biochemical hypercalcemia or any clinical presentation associated with hypercalcemia must be evaluated for pHPT.

  • The value of blood cell markers in patients with thyroid nodules including atypia of undetermined significance/follicular lesion of undetermined significance cytology

    by Dilek Arpaci, Guldeniz Karadeniz Cakmak, Ali Ugur Emre, Mustafa Unal, Fatih Kuzu, Burak Bahadir, Muammer Bilici, Taner Bayraktaroglu

    Background: Atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) is a heterogeneous that cannot be definitively diagnosed as benign, malignancy-suspect, or malignant. The estimated risk of AUS/FLUS malignancy is reported 5% to 15% according to the Bethesda System (BS). This study was conducted to evaluate the ability of mean platelet volume (MPV) and neutrophil-to-lymphocyte ratio (NLR) to predict the malignant potential of nodules diagnosed as AUS/FLUS. Materials and Methods: We retrospectively analyzed 101 patients for whom thyroid fine needle aspiration biopsy (FNAB) analysis indicated AUS/FLUS and who underwent surgery between 2011 and 2015. Demographic, laboratory, and histopathological data were obtained from a database. The patients were categorized into two groups: malignant or benign and comparisons between groups were performed. Results: The mean age was 49.01±11.59 (20–80) years, the mean TSH level was 2.04±2.09 μIU/ml. (0.01–11.87), the mean FT4 level was 0.98±0.43 pg/ml (0.54–3.96), and the mean FT3 level was 3.71±0.80 pg /ml, (2.15–7.46). Of the 101 patients, 26 (25.7%) had solitary nodules and 75 (74.3%) had multinodulary goiter. The malignancy rate (cytological atypia) was 33.7%, and there were no differences between the two groups in terms of age, gender, or TSH or FT4 levels. Median preoperative red cell distribution width (RDW) level was 13.4 inthe benign group, while it was 14.4 in patients with malignancy, demonstrating a significant correlation (P=0.034) Both MPV and NLR were elevated in malignant nodules. Conclusions: The malignancy risk of AUS/FLUS evident upon thyroid FNAB was higher than anticipated by the BS. MPV, NLR and RDW are useful for estimating the malignancy risks of these diseases.

  • Open Access

    Focused parathyroidectomy without intra-operative parathormone monitoring: The value of PTH assay in preoperative ultrasound guided fine needle aspiration washout

    by Fatih Kuzu, Dilek Arpaci, Guldeniz Karadeniz Cakmak, Ali Ugur Emre, Tarik Elri, Sevil Uygun Ilikhan, Burak Bahadir, Taner Bayraktaoglu

    The accurate identification of hyperfunctioning parathyroid (HP) gland is the only issue for definitive surgical treatment in primary hyperparathyroidism (pHPT). Various imaging and operative techniques have been proposed to confirm the localization of the diseased gland. Nevertheless, none of these methods proved to be the gold standard. The presented study aimed to assess the value of parathyroid hormone assay in preoperative ultrasound guided fine needle aspiration (FNA)-PTH washout fluid to verify the correct localisation for focused parathyroidectomy without intra-operative PTH monitoring. The retrospective analysis of 57 patients with pHPT who underwent FNA-PTH was conducted from a prospective database. Biochemical assessment together with radiological (ultrasonography) and nuclear (MIBI scan) imaging was reviewed. Associations between FNA-PTH washout values and localization technics were evaluated and compared in terms of operative findings. Focused parathyroidectomy without intraoperative PTH monitoring was performed to 45 patients with high FNA-PTH values. The median largest diameter of the target parathyroid lesion identified by ultrasonography was 13 mm (range, 6 to 36). The median serum PTH level was 190 pg/mL (range, 78 to 1709; reference range, 15 to 65) whereas the median washout PTH was 2500 pg/mL (range, 480 to 3389). According to operative findings high FNA-PTH levels correctly identified parathyroid adenoma in 40 cases (89% of sensitivity and 100% of specificity and positive predictive value) whereas MIBI scan localized the lesion in 36 of these cases (80% of sensitivity). The higher level of PTH in preoperative ultrasound guided FNA washout is a considerable data to predict the correct localization of HP, particularly in circumstances of greater values than the serum PTH level. However, although its specificity is high, in cases of coexisting nodular thyroid disease, associated additional HP might be missed at focused parathyroidectomy without PTH monitoring, leading to recurrent disease.